Breaking: Robert W. Baird Reconfirms $92.0000 PT On Express Scripts (NASDAQ:ESRX) Shares, Reconfirms Their Original Buy Rating

May 18, 2018 - By Ann Prendergast

Express Scripts Holding Company (NASDAQ:ESRX) Logo

Investors sentiment increased to 0.69 in 2017 Q4. Its up 0.07, from 0.62 in 2017Q3. It increased, as 68 investors sold Express Scripts Holding Company shares while 407 reduced holdings. 111 funds opened positions while 216 raised stakes. 479.40 million shares or 1.52% less from 486.80 million shares in 2017Q3 were reported.

Jolley Asset Mgmt Ltd Limited Liability Company owns 257 shares or 0.01% of their US portfolio. New York-based Fred Alger Mgmt Inc has invested 0% in Express Scripts Holding Company (NASDAQ:ESRX). Umb Bank N A Mo reported 4,634 shares. 74,880 are held by Williams Jones & Lc. Moreover, Chevy Chase Tru Hldg Incorporated has 0.16% invested in Express Scripts Holding Company (NASDAQ:ESRX) for 499,484 shares. Hemenway Communications Limited Liability holds 2,970 shares or 0.04% of its portfolio. Gotham Asset Mngmt Lc holds 710,916 shares. Dumont & Blake Invest Advisors Ltd Llc holds 0.4% or 13,226 shares in its portfolio. 13,911 are held by Moors And Cabot. Brookstone Mngmt invested in 0.02% or 3,634 shares. Ipswich Invest Comm holds 4,378 shares. Associated Banc invested in 0.03% or 7,759 shares. Bb&T Corporation invested 0.08% in Express Scripts Holding Company (NASDAQ:ESRX). Dixon Hubard Feinour Brown Incorporated Va holds 4,295 shares or 0.09% of its portfolio. Bb&T Ltd Liability Corp accumulated 0.14% or 143,424 shares.

Express Scripts (NASDAQ:ESRX) Rating Reaffirmed

They currently have a $92.0000 TP on Express Scripts (NASDAQ:ESRX). The target price by Robert W. Baird would suggest a potential upside of 20.50 % from the company’s current stock price. This has been shown in a research report on 17 May.

Express Scripts Holding Company (NASDAQ:ESRX) Ratings Coverage

Among 16 analysts covering Express Scripts Holding (NASDAQ:ESRX), 5 have Buy rating, 2 Sell and 9 Hold. Therefore 31% are positive. Express Scripts Holding has $96.0 highest and $68.0 lowest target. $82.42’s average target is 7.95% above currents $76.35 stock price. Express Scripts Holding had 28 analyst reports since December 4, 2017 according to SRatingsIntel. The stock of Express Scripts Holding Company (NASDAQ:ESRX) has “Sell” rating given on Tuesday, January 30 by Bernstein. William Blair maintained the stock with “Hold” rating in Thursday, March 29 report. The stock of Express Scripts Holding Company (NASDAQ:ESRX) has “Sell” rating given on Friday, December 15 by Raymond James. The company was maintained on Wednesday, December 20 by SunTrust. The firm has “Underperform” rating by Bernstein given on Thursday, February 1. SunTrust maintained Express Scripts Holding Company (NASDAQ:ESRX) on Thursday, December 14 with “Buy” rating. The firm has “Hold” rating by Wells Fargo given on Friday, March 9. The rating was downgraded by Jefferies on Thursday, March 8 to “Hold”. On Monday, March 12 the stock rating was upgraded by Bernstein to “Market Perform”. RBC Capital Markets upgraded Express Scripts Holding Company (NASDAQ:ESRX) on Wednesday, January 31 to “Outperform” rating.

The stock increased 3.55% or $2.62 during the last trading session, reaching $76.35. About 5.50 million shares traded or 8.38% up from the average. Express Scripts Holding Company (NASDAQ:ESRX) has risen 8.93% since May 18, 2017 and is uptrending. It has underperformed by 2.62% the S&P500.

Analysts await Express Scripts Holding Company (NASDAQ:ESRX) to report earnings on July, 24. They expect $2.24 EPS, up 29.48 % or $0.51 from last year’s $1.73 per share. ESRX’s profit will be $1.26 billion for 8.52 P/E if the $2.24 EPS becomes a reality. After $1.77 actual EPS reported by Express Scripts Holding Company for the previous quarter, Wall Street now forecasts 26.55 % EPS growth.

Express Scripts Holding Company operates as a pharmacy benefit management firm in the United States, Canada, and Europe. The company has market cap of $42.89 billion. It operates in two divisions, PBM and Other Business Operations. It has a 9.86 P/E ratio. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services.

More recent Express Scripts Holding Company (NASDAQ:ESRX) news were published by: which released: “Even After Earnings Beat, Cigna Corporation Stock Still Looks Stuck” on May 11, 2018. Also published the news titled: “Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more…) -13F” on May 15, 2018.‘s news article titled: “ValueAct’s 13F Shows New Stake in SLM Corp (SLM), Confirms Increase in Citi (C), Exits Microsoft (MSFT) (more…)” with publication date: May 15, 2018 was also an interesting one.

Express Scripts Holding Company (NASDAQ:ESRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: